We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Richard Lafferty has been assisting clients through the H1B Visa process since 2021.

As of 2022, Richard Lafferty has succesfully submitted and recieved certification for 154 cases.

Richard Lafferty is located in New York, NY, and has represented 5 employers for the H1B Visa Process

155
Cases Handled
154
Cases Certified
99.35%
Approval

Cases Handled by Richard Lafferty

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-22081-997005 Certified Bioinformatics Scientists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2022
I-200-23230-275658 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2023
I-200-23199-195505 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2023
I-200-23152-067834 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2023
I-200-23143-047412 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2023
I-200-23142-043335 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2023
I-200-23067-832759 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2023
I-200-22146-217203 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2022
I-200-22146-216719 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2022
I-200-22143-199911 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2022